All In Biotech

Drug Trial Radar · NCT05418244

Inhaled Isopropyl Alcohol for Treatment of Nausea

Inhaled Isopropyl Alcohol for the Treatment of Nausea in a Pediatric Emergency Department: A Open Label, Randomized Controlled Clinical Trial

Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

Apr 20, 2022

Primary completion

Jun 30, 2027

Study completion Jun 30, 2027

Sponsor

Lead sponsor
State University of New York at BuffaloAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 14, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 7 years, up to 17 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.

Conditions

  • Vomiting
  • Nausea
  • Children, Only

Interventions

  • Inhaled Isopropyl AlcoholOther

    Isopropyl alcohol pad (Covidien Webcol 2 ply prep pads, saturated with 70% isopropyl alcohol) held 1-2 cm under the subject's nares

  • Oral OndansetronDrug

    4 mg oral disintegrating ondansetron tablet once

  • Inhaled PlaceboOther

    Normal saline pad (Hygea sterile saline wipe) held 1-2 cm under the subject's nares

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Nausea Score at 30 MinutesTime frame: 30 minutes post-intervention as compared to baseline
  2. Change in Nausea Score at 10 MinutesTime frame: 10 minutes post-interventnon as compared to baseline
  3. Change in Nausea Score at DischargeTime frame: At ED discharge (assessed up to 10 hours) as compared to baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Oishei Children's Hospital

    Buffalo, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.